Author:
Kazandjian Dickran,Landgren Ola
Reference9 articles.
1. A look backward and forward in the regulatory and treatment history of multiple myeloma: approval of novel-novel agents, new drug development, and longer patient survival;Kazandjian;Semin Oncol,2016
2. CAR T and CAR NK cells in multiple myeloma: expanding the targets;Shah;Best Pract Res Clin Haematol,2020
3. Idecabtagene vicleucel in relapsed and refractory multiple myeloma;Munshi;N Engl J Med,2021
4. Bispecifics, trispecifics, and other novel immune treatments in myeloma;Lancman;Hematology,2020
5. Preclinical activity of JNJ-7957, a novel BCMA×CD3 bispecific antibody for the treatment of multiple myeloma, is potentiated by daratumumab;Frerichs;Clin Cancer Res,2020
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献